Top

Tag: Pharmaceuticals


Cell and Gene Therapy, Industry, News

Catalent Appoints Open Innovation, Biologics, Cell and Gene Therapy VP

November 19, 2020

Via: Contract Pharma

Catalent has appointed Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy. In this new role, Dr. Mahdavi will join a team of experts in Catalent’s Science and Technology Group that works with customers […]


Industry, Vaccines

COVID-19 Nanoparticle Vaccine Elicits High Levels of Protective Antibodies in Mice

November 3, 2020

Via: Genetic Engineering and Biotechnology News

There are currently hundreds of COVID-19 vaccine candidates in development around the world. Some of the challenges facing them are the requirement of large doses, complex manufacturing, and cold-chain shipping and storage. An ultrapotent vaccine that is safe, effective at […]


FDA, Regulations

Spectrum Pharmaceuticals Sees Delay from FDA on Eflapegrastim BLA

October 26, 2020

Via: BioSpace

Spectrum Pharmaceuticals announced today that an inspection of the Hanmi Bioplant in South Korea will be necessary before the U.S. Food and Drug Administration (FDA) can approve its Biologics License Application (BLS) for ROLONTIS (eflapegrastim). Because of the COVID-19 pandemic, […]


Industry, Vaccines

COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO

October 20, 2020

Via: FierceBiotech

The biotech behind AstraZeneca and the University of Oxford’s late-stage pandemic vaccine has hired Margaret (Meg) Marshall, M.D., as its new chief medical officer. Marshall joined as a consultant to Oxford spinout Vaccitech in the summer, but she now jumps […]


Manufacturing, Research and Development

CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

October 20, 2020

Via: Contract Pharma

CNS Pharmaceuticals Inc.’s U.S. manufacturer, Pharmaceutics International Inc., has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable. “Completing the manufacturing […]


Industry, Vaccines

Vaccines Market: Emergence of New Selling Points to Aid Market Growth

October 2, 2020

Via: BioSpace

The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention, finds Transparency Market Research (TMR). There is a high probability of new vendors emerging in the […]


Manufacturing, Research and Development

The Future of Drug Discovery

September 29, 2020

Via: Genetic Engineering and Biotechnology News

For far too long, cell culture experiments lacked dimensionality and not abstractly, but in the actual physical sense. Scientists were forced to grow their cells in only two dimensions, creating monolayers that are unrepresentative of true in vivo conditions. But […]


Biotech, Industry

Genetic Engineering Across the Tree of Life

September 21, 2020

Via: Genetic Engineering and Biotechnology News

Industrial bioengineering is now using genetically modified microbes to produce a wide array of products at industrial scale, including everything from biofuels to nutraceuticals such as resveratrol. But despite the diversity of output, the primary organisms producing them are modified […]


Industry, Vaccines

Automation a Key Focus for Moderna’s COVID-19 Vaccine Contractor

September 15, 2020

Via: Genetic Engineering and Biotechnology News

Moderna hired Lonza to make its COVID-19 vaccine in May. Initially, the CDMO will manufacture the vaccine active ingredient—an mRNA molecule in lipid nanoparticles—at plants in the United States and Switzerland. However, the firms plan to establish additional production suites […]


Industry, News, Pharma

Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04

September 15, 2020

Via: BioSpace

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received a formal notice of allowance from the U.S. Patent […]


Industry, Pharma

Drug Targets Identified More Discerningly

September 1, 2020

Via: Genetic Engineering and Biotechnology News

Experimental drugs face steep odds. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), out of every 5,000 to 10,000 compounds that enter the discovery and development pipeline, just 5 enter clinical trials, and only 1 receives approval. Other […]


Industry, Vaccines

AstraZeneca nets $396M down payment from EU for 300M-plus COVID vaccines

August 28, 2020

Via: FiercePharma

AstraZeneca has been on roll lately, inking COVID-19 vaccine supply deals left and right with countries worldwide. One of its highest-profile pacts—a purchase deal with the European Union—was made official earlier this month, and now, the trading bloc has floated […]